on SARTORIUS STED BIO (EPA:DIM)
Availability of the 2024 Universal Registration Document by Sartorius Stedim Biotech
Aubagne-based Sartorius Stedim Biotech announced that its Universal Registration Document for 2024 is now available online. This document includes the evolution of the company's activities for the year 2024, as well as the objectives set for 2025. It also presents the consolidated financial statements as of December 31, 2024. This document is accessible via the company's website, in the investor relations section.
Sartorius Stedim Biotech continues to position itself as a major player in the biopharmaceutical industry thanks to its innovative solutions. In 2024, the company generated sales of around €2.8 billion. With more than 9,900 employees worldwide, the group is continuing its international development, relying on its manufacturing and research sites in Europe, North America and Asia.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SARTORIUS STED BIO news